Edition:
United States

STRATA Skin Sciences Inc (SSKN.OQ)

SSKN.OQ on NASDAQ Stock Exchange Capital Market

1.20USD
20 Apr 2018
Change (% chg)

$-0.01 (-0.83%)
Prev Close
$1.21
Open
$1.21
Day's High
$1.21
Day's Low
$1.20
Volume
17
Avg. Vol
9,262
52-wk High
$4.88
52-wk Low
$1.06

Chart for

About

STRATA Skin Sciences, Inc., formerly MELA Sciences, Inc., is a medical technology company. The Company is engaged in developing and commercializing products for the diagnosis and treatment of dermatological disorders. The Company has three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment and... (more)

Overall

Beta: 0.70
Market Cap(Mil.): $4.89
Shares Outstanding(Mil.): 4.08
Dividend: --
Yield (%): --

Financials

  SSKN.OQ Industry Sector
P/E (TTM): -- 33.54 33.25
EPS (TTM): -1.35 -- --
ROI: 14.71 9.93 13.13
ROE: 27.07 14.73 14.96

BRIEF-Strata Skin Sciences Inc - ‍On March 30, 2018, Co Entered Into Securities Purchase Agreements And Subscription Agreements -- SEC Filing​

* CO WILL ISSUE 15.7 MILLION SHARES OF CO'S COMMON STOCK TO A GROUP OF INVESTORS LED BY ACCELMED GROWTH PARTNERS L.P. FOR $17.0 MILLION

Apr 02 2018

BRIEF-STRATA Skin Sciences Appoints Dolev Rafaeli As Interim CEO

* STRATA SKIN SCIENCES ANNOUNCES $17 MILLION EQUITY FINANCING LED BY ACCELMED GROWTH PARTNERS; APPOINTMENT OF INDUSTRY VETERAN AS INTERIM CEO

Apr 02 2018

BRIEF-Strata Skin Sciences Delays Q4 Results Partly Due To Extended Power Outage At Horsham

* STRATA SKIN SCIENCES, INC. DELAYS FOURTH QUARTER AND FISCAL 2017 FINANCIAL RESULTS

Mar 06 2018

BRIEF-Strata Skin Sciences reports Q3 loss of $5.52 per share

* Strata skin sciences reports third quarter 2017 financial results

Nov 09 2017

BRIEF-Leviticus Partners reports 9.69 pct passive stake in Strata Skin Sciences

* Says reports 9.69 pct passive stake in Strata Skin Sciences Inc as of Oct 24, 2017 - SEC filing‍​ Source text - (http://bit.ly/2h6vUO5)

Nov 02 2017

Competitors

Earnings vs. Estimates